TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.

Saved in:
Bibliographic Details
Title: TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.
Authors: Zhao, Ken1 (AUTHOR) petree@mskcc.org, Karimi, Anita1 (AUTHOR) marinelb@mskcc.org, Kelly, Luke1 (AUTHOR) alexane@mskcc.org, Petre, Elena1 (AUTHOR) sotirchv@mskcc.org, Marinelli, Brett1 (AUTHOR) erinjerj@mskcc.org, Alexander, Erica S.1 (AUTHOR) coveya@mskcc.org, Sotirchos, Vlasios S.1 (AUTHOR) sofoclec@mskcc.org, Erinjeri, Joseph P.1 (AUTHOR) zive@mskcc.org, Covey, Anne1 (AUTHOR) yarmohah@mskcc.org, Sofocleous, Constantinos T.1 (AUTHOR), Harding, James J.2 (AUTHOR) hardinj1@mskcc.org, Jarnagin, William3 (AUTHOR) jarnagiw@mskcc.org, Sigel, Carlie4 (AUTHOR) sigelc@mskcc.org, Vakiani, Efsevia4 (AUTHOR) vakianie@mskcc.org, Ziv, Etay1 (AUTHOR), Yarmohammadi, Hooman1 (AUTHOR)
Source: Current Oncology. Jan2025, Vol. 32 Issue 1, p51. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol32010051